THE ROBERT H. LURIE COMPREHENSIVE CANCER CENTER of Northwestern University and Tempus, a health-tech company focused on helping doctors personalize cancer care, announced a partnership that will make Tempus as a preferred partner to handle genomic sequencing and analysis as part of Lurie Cancer Center’s new OncoSET initiative. Lurie Cancer Center launched the OncoSET (Sequence,...
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
